The Medicare Drug Benefit:
Update on the Low-Income Subsidy

Mary Ellen Stahlman, Principal Policy Analyst
OVERVIEW — The Medicare drug benefit (Medicare "Part

D"), provides federal subsidies to pay premiums and cost
sharing for low-income beneficiaries—almost 10 million in
2009. Yet there are several policy issues concerning these
low-income beneficiaries under Part D. First, over 2 million individuals who may qualify for the subsidies have not
enrolled. Second, in some states, low-income beneficiaries
have little choice of plans (while non low-income beneficiaries have dozens of choices), unless they pay out-of-pocket
for premium amounts above what the subsidy covers. And
third, millions of those who have enrolled in the benefit face
the prospect each year of switching drug plans or paying
more to keep their current drug plan. What led to this state
of affairs? Are there lessons to be learned from Medicare
Part D as Congress debates how to provide health insurance
subsidies on behalf of low-income individuals?
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T

he Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) established a voluntary
outpatient prescription drug benefit (“Part D”), for Medicare
beneficiaries. The Medicare drug benefit began January 1,
2006, and is administered through private prescription drug
plans (PDPs) for beneficiaries in fee-for-service Medicare1
and through Medicare Advantage drug plans (MA-PDs) for
beneficiaries enrolled in Medicare managed care plans. The
private drug plans compete for enrollment based on the premiums, benefit package (including a formulary, that is, the
list of drugs it covers), cost-sharing, pharmacy network and
other drug plan attributes. Organizations intending to offer
a Medicare drug benefit submit bids to the Centers for Medicare & Medicaid Services (CMS), and beneficiary premiums
are derived from the bids.2 The lower a plan’s bid, the lower its beneficiary premium. Beneficiaries dually eligible for
both Medicare and Medicaid and many other low-income
beneficiaries may enroll in a drug plan without having to
pay a monthly premium if they select a basic benefit plan
with a premium that is at or below an amount called the
low-income benchmark premium (an average premium, described in more detail later in this paper).
Several issues related to low-income individuals under Part D concern policymakers. First, an estimated 2 million low-income beneficiaries who may be eligible for federal subsidies of their drug
coverage are not enrolled. It is not known if these beneficiaries are
foregoing federally subsidized drug coverage purposefully or due to
a lack of awareness.
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Second, there is considerable geographic variation in the number
of PDPs being offered premium-free to low-income beneficiaries; in
2009, there is only 1 plan in Nevada but 16 plan choices in Wisconsin.
Beneficiaries may also select an MA-PD, but those preferring to stay
in fee-for-service Medicare have few choices in some states.

ISSUE BRIEF

www.nhpf.org

No. 833

Third, the plans that are offered premium-free have changed from
one year to the next. As the plans offered premium-free to low-income beneficiaries change, millions of low-income beneficiaries are
faced with switching drug plans or paying the difference between
their plan’s premium and the low-income benchmark premium.
About 23 percent of low income beneficiaries enrolled in Part D—2.2
million people—faced with this dilemma in 2009 alone.3
Some beneficiaries not qualifying for extra assistance, many of whom
are also living on limited means, make difficult choices in the face of
health care cost increases. However, the lowest income beneficiaries
are least able to pay additional premium amounts or adapt easily to
the formulary and procedures of new prescription drug plans.

D rug Ben efit Ba si c s
Over 45.24 million Medicare beneficiaries are eligible for Medicare Part
D, including low-income and non low-income beneficiaries. Of those,
nearly 41 million—over 90 percent—have prescription drug coverage
through sources including “stand-alone” PDPs or MA-PDs, a former
employer receiving a Medicare retiree
Figure 1
drug subsidy,4 or other sources such as
Sources of Drug Coverage for Medicare Beneficiaries, 2009
the Veterans Administration, a current
employer, a Medicare supplemental (or
Total Medicare beneficiaries eligible for Part D
45.24 million beneficiaries
Medigap) policy, or the Indian Health
Service. About 4.46 million beneficiaries,
Medicare beneficiaries with
Stand-alone
including roughly 2 million low-income
no known source of coverage
drug plans
4.46
individuals, have no known source of
drug coverage. (See Figure 1, right.)
The vast majority of Medicare beneficiaries are enrolled in PDPs and MAPDs—17.48 million and 9.17 million,
respectively, in 2009. Those beneficiaries can choose among dozens of plan
options available in each of 34 regions
across the country. While the number
of options varies from region to region,
most beneficiaries can choose from of
about 50 PDPs and dozens of MA-PDs.
Beneficiaries enrolling in a drug plan
pay monthly premiums, in addition to

9.17

Medicare health plans,
including Medicare Advantage

5.97

Retiree drug subsidy

17.48

8.16
Other drug coverage*
* Other coverage includes: TRICARE, FEHBP, VA, active workers with Medicare secondary
payer, retirees in plans not receiving the retiree drug subsidy, Medigap, Indian Health Service,
and state pharmaceutical assistance programs.
Source: Centers for Medicare & Medicaid Services, 2009 Enrollment Information, Total
Medicare Beneficiaries with Prescription Drug Coverage, as of February 1, 2009, available at
www.cms.hhs.gov/PrescriptionDrugCovGenIn.
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cost sharing and any deductible.5 The standard benefit package in 2009
consists of a $295 yearly deductible, 25 percent coinsurance for drug
spending between $295 and $2,700, and 100 percent coinsurance after
the beneficiary reaches $2,700 until $4,350 is spent out of pocket (a gap
in coverage popularly known as the “donut hole”). After a beneficiary
spends $4,350 out of pocket, catastrophic coverage begins which reduces cost sharing to a minimal amount. Most beneficiaries are enrolled in
plans that have an alternative benefit package that has the same benefit
value (that is, it is actuarially equivalent) to the standard benefit.
Medicare subsidizes the cost of the drug benefit for all enrollees, paying 74.5 percent of program costs. Federal expenditures for Medicare
Part D are expected to total almost $63 billion in 2009.6 Medicare
makes additional payments to drug plans to subsidize the premiums,
cost sharing, and deductibles of beneficiaries with limited income
and assets. This is known as the low-income subsidy (LIS). In 2009,
drug plans are expected to be paid an average of $1,105 per enrollee
for drug benefits and another $1,950 per low-income enrollee to subsidize the additional benefits available to them.7 About one-third of total Medicare outlays for Part D are for these additional LIS payments.
Of the 26.65 million beneficiaries enrolled in PDPs and MA-PDs in
2009, over one-third (9.67 million) are enrolled in the LIS program.8

LOW - I NCO M E BEN EFI C I A RI ES I N PA R T D
An estimated 12.5 million beneficiaries are eligible for extra benefits
under Part D including payment of drug plan premiums, co-pays and
deductibles. However, only 9.67 million of those potentially eligible
for Part D and the extra benefits are enrolled in 2009, despite federal
and local efforts to increase awareness of the benefit and enroll them.
Eligib ili t y a n d B e n e f i t s

The LIS program significantly reduces out-of-pocket costs, including no or lower beneficiary premiums and limited cost-sharing (Figure 2, next page). Unlike non low-income beneficiaries, beneficiaries
qualifying for the LIS continue to have their prescription drugs paid
for through the donut hole.
Beneficiaries become eligible for the LIS when their incomes are at or
below 150 percent of the federal poverty level ($16,245 for an individual
and $21,855 for a couple in 2009) and they have limited assets ($11,010
4
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for an individual and $22,010 for a couple in 2009).9 The amount of assistance varies, depending on the income and assets of the beneficiary.
In other words, lower income beneficiaries receive the most assistance,

FIGURE 2
The Low-Income Subsidy:
Extra Assistance in 2009
for Beneficiaries with
Limited Means

An estimated 12.5 million Medicare beneficiaries have annual incomes
of less than 150 percent of the federal poverty level ($16,245 for an
individual; $21,855 for a couple) and meet certain asset requirements,
making them eligible for financial help with their Part D premiums,
deductibles, and copays. The amount of assistance available depends
on the income and asset levels of the beneficiary.
Beneficiary Groups

Full Benefit Dual Eligibles*

Income

<100% FPL

Non-Full Benefit Dual Eligibles

>100% FPL		
$6,600
$9,910

Individual
N/A†
N/A†
Assets Couple			
‡

‡

‡

but

<$11,010

<$11,010
<$22,010

but <$22,010
‡

100%

100%

100%

100%

Partial (see “Sliding Scale”)

Deductible

None

None

None

$60

$60

Copay (generic/brand) §

$1.10/$3.20

$2.40/$6.00

$2.40/$6.00

15% coinsurance

15% coinsurance

Above Catastrophic
Limit?¶

No cost
sharing

No cost
sharing

No cost
sharing

$2.40/$6.00 copay

$2.40/$6.00 copay

For beneficiaries with incomes at or above
135% FPL and with assets valued above $11,010
(for an individual, or $22,010 for a couple), the
amount of premium subsidy decreases. Beneficiaries with incomes at or above 150% FPL
receive no drug plan premium subsidy.

Sliding Scale: Partial Premium Subsidies
Full Subsidy

* Individuals who are not living in an institution. Institutionalized
‡

>$6,600
>$9,910

>135% to 150% FPL

Premium Subsidy (%)

Premium Subsidies Taper Off for
Dual Eligibles with Larger Incomes

†

<135% FPL		

dual eligibles are exempt from all cost sharing.
Asset tests vary by state for full-benefit dual eligibles.
No premium is required if the individual selects a PDP with a
premium less than or equal to the low-income benchmark.

135%

No Subsidy
140%

75% of
Premium Subsidy

145%

50% of
Premium Subsidy

150%

25% of
Premium Subsidy

Percent of Federal Poverty Level

§

Copayment and deductible amounts are indexed in future years.
The catastrophic limit is defined as the point at which an individual has
spent $4,350 out of pocket on covered drugs in 2009.
Sources: CMS-4068-F, Federal Register, January 28, 2005, pp. 4388–4389;
and CMS Announcement, April 6, 2009, available at www.cms.hhs.gov/
MedicareAdvtgSpecRateStats/Downloads/Announcement2010.pdf.
¶
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including payment of the monthly drug plan premium if they enroll
in an eligible plan.
As Figure 2 shows, beneficiaries with incomes below 135 percent of
the federal poverty level and few assets generally pay no monthly
drug premium, most pay no deductible, and all have lower cost sharing amounts than non low-income beneficiaries. Beneficiaries with
incomes at or above 135 percent of FPL but below 150 percent of FPL
pay premiums on a sliding scale according to income, and have lower
deductibles and coinsurance than beneficiaries not receiving the LIS.
En ro llm e n t a n d Au to - e n ro llm e n t

Some low-income beneficiaries automatically qualify for LIS, whereas others must apply for it. Groups of beneficiaries automatically
qualifying for LIS include: beneficiaries eligible for both Medicare
and Medicaid (“dual eligibles”), beneficiaries who receive supplemental security income (SSI) but are not dually eligible, and beneficiaries enrolled in Medicare Savings Programs (federal-state programs that help low-income beneficiaries pay Medicare premiums,
deductibles, and copayments). Beneficiaries who do not fall into one
of these three groups but believe they meet the income and asset
requirements may apply for LIS benefits, either through a state office
or the Social Security Administration (SSA).
LIS beneficiaries receive assistance with enrollment in a drug plan.
Those who automatically qualify for the LIS but do not choose a
prescription drug plan on their own are automatically enrolled, or
“auto-enrolled,” in one by Medicare when they first qualify for LIS.
Beneficiaries who apply for and receive LIS, but then fail to select a
plan, are also enrolled by Medicare (often referred to as “facilitated
enrollment”). When a beneficiary does not choose a plan on his own,
he is randomly assigned to a drug plan with a basic benefit package
that has a premium at or below the low-income benchmark premium. Low-income beneficiaries, including those randomly assigned
to a plan, are free to change plans during the year, whereas beneficiaries not receiving LIS may only change plans during an open
enrollment period in late fall.
Auto-enrollment helps ensure that as many known low-income beneficiaries as possible are enrolled in a drug plan. However, there is no
guarantee that the plan to which a beneficiary is randomly assigned
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has a formulary that includes the drugs the beneficiary is taking.
For this reason, some have suggested that plan assignment take into
account what drugs a beneficiary is taking and other factors unique
to an individual beneficiary.10 Conversely, so-called “beneficiarycentered assignment” could increase the number of beneficiaries
changing plans each year as beneficiaries are moved into plans that
better meet their needs. And, plan costs could increase as more beneficiaries are auto-enrolled into plans because their formulary includes the needed drugs. These unintended consequences would
need to be thought through before a policy change is made.
As Table 1 indicates, many beneficiaries—an estimated 2.34 million in
2009—may be eligible for low-income assistance but are not enrolled.
There are many reasons why such a large share of eligible individuals
would not enroll in Part D or fail to enroll in the LIS; factors that may
play a role include lack of awareness, perceived lack of need (particularly for beneficiaries with no drug spending), language barriers, mental illness, low
TABLE 1: Medicare Beneficiaries Eligible for
literacy, other coverage not known to MediLow-Income Subsidy (by Source of Coverage), 2006–2009
care, and personal preference. Beneficiaries
LIS-Eligible Beneficiaries (millions)
may also experience a change in circumstances that qualifies them for LIS, such
2006
2007
2008*
2009*
as loss of a spouse, or change in income or
Estimated Total LIS13.20
13.20
12.50
12.50
Eligible Beneficiaries
assets, but fail to connect the change to potential eligibility.
CMS (the agency that oversees Medicare),
SSA, and numerous advocacy organizations have undertaken efforts to reach out
to and enroll beneficiaries potentially eligible for LIS. SSA, for example, sends letters
to beneficiaries who the agency believes
may be eligible for LIS based on the amount
of their Social Security benefit. CMS has
worked with beneficiary groups to identify
and implement best practices for locating
and enrolling potentially eligible beneficiaries, particularly those with limited English
proficiency and low literacy. CMS has been
trying multiple approaches to targeting
potentially eligible individuals, including
identifying and focusing outreach efforts

Total Drug Coverage
from Medicare**

9.0

9.18

9.42

9.67

Other Sources of
Creditable Coverage
(VA, IHS, SPAPs)

1.0

0.72

0.42

0.42

N/A

0.03

0.06

0.01

3.2

3.27

2.60

2.34

Anticipated Facilitated
Enrollments
Potentially Eligible
but Not Enrolled

* Starting in 2008, CMS changed the method of estimating the number of low-income
eligible beneficiaries, lowering the estimate from 13.20 in 2006 and 2007 to 12.5 million
in 2008 and 2009. (Table numbers here may not total 12.5 million due to rounding.)
** Includes enrollment in PDPs and MA-PDs. For 2008 and 2009 includes beneficiaries
who qualify for LIS but for whom their employer received a retiree drug subsidy on
their behalf (approximately 40,000 in 2008 and 30,000 in 2009).
Source: Centers for Medicare & Medicaid Services, 2009 Enrollment Information, LISEligible Medicare Beneficiaries with Drug Coverage, available at www.cms.hhs.gov/
PrescriptionDrugCovGenIn.
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on ZIP codes that have high numbers of beneficiaries who are potentially eligible for the LIS, but not enrolled.11
CMS has also conducted focus groups, telephone interviews and other qualitative research in an effort to better understand reasons why
low-income beneficiaries have not enrolled in Part D. For example,
CMS research indicates that urban beneficiaries prefer to learn about
LIS directly from Medicare or the SSA, rather than local beneficiary
groups that seem to be a trusted information source for other beneficiaries. Rural beneficiaries who have not enrolled seem to be wary of

H ow Pa r t D Wo r k s fo r L ow - I n co m e Re s i d e n t s of
U. S . Te r ri to rie s a n d I n dia n Re s e r va tio n s

While many of the features of Medicare Part D are the same for non low-income beneficiaries
who reside in the territories or receive their health care from Indian Health Service facilities,
there are a few important differences.
Residents of U.S. Territories — Over 650,000

Medicare beneficiaries reside in the U.S. territories (including Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa and
Northern Mariana Islands).* Much of the design of Medicare Part D is the same in the
territories as it is on the U.S. mainland. Plan
design (including cost sharing and deductibles), bidding, and plan contracting are all
similar. However, low-income beneficiaries
residing in the territories are not eligible for
the LIS. Instead, the territories receive a grant
of federal Medicaid funds to permit each territory’s Medicaid program to “wrap around”
Medicare drug coverage for beneficiaries dually eligible for both Medicare and Medicaid.
This wrap-around benefit is only available
to full dual eligible beneficiaries. Non–dual
eligible beneficiaries under 150 percent of the
federal poverty line—who would be eligible

for assistance with premiums and cost sharing if they resided in the U.S. mainland—
are not eligible for the extra benefits which
are funded with Medicaid dollars, and the
non-duals are not Medicaid recipients.
Indian Health Service — While Medicare Part

D works the same for American Indians
and Alaska natives as for any beneficiary,
some do not enroll in Part D or the LIS.
Most American Indians and Alaska Natives receive health care services free of
charge at Indian Health Service (IHS) facilities, including prescription drugs. From
the beneficiary perspective, there is little
need to enroll in Part D because prescription drugs are already free. However, the
IHS encourages beneficiaries to enroll in
Part D, particularly if they may qualify for
the LIS, so that Medicare is the primary
payer for these Medicare beneficiaries.

* State Health Facts, “Distribution of Medicare Beneficiaries by Age, 2004,” Kaiser Family Foundation”; available at
www.statehealthfacts.org/comparetable.jsp?ind=292&cat=6.
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providing personal information to anyone, have a strong sense of independence that might hinder enrollment in a public program, and
are less likely than urban beneficiaries to contact Medicare or SSA
for information about federal programs.12 CMS is using this type of
feedback to target the method, means, and type of communication it
has with potentially eligible beneficiaries. Despite targeted interventions, however, many beneficiaries, including low-income beneficiaries, remain unenrolled.
The failure of low-income persons to enroll in available subsidy
programs is not unique to Medicare Part D. While it is difficult to
estimate the number of potentially eligible individuals for any program, some analysts believe that millions of Americans are eligible
for, but not enrolled in, other federally subsidized health insurance
programs including Medicaid, the Children’s Health Insurance Program, and Medicare Savings Programs.13

VA RI AT I O N I N D RUG PLAN AVA I LA BI L I T Y
Low-income beneficiaries make up a sizeable share of enrollment in
PDPs and MA-PDs. About 45 percent of the beneficiaries enrolled
in PDPs and about 17 percent of beneficiaries enrolled in MA-PDs
receive the LIS.14 However, not all individual drug plans have a large
share of low-income beneficiaries. Because Medicare only pays the
full premium of basic benefit package drug plans that have premiums at or below the average in a geographic area, the great majority
of LIS beneficiaries are in below-average cost plans.15 The average
beneficiary premium in an area, weighted by enrollment of LIS beneficiaries, is called the low-income benchmark premium.16 If a lowincome beneficiary selects a plan with a premium above the lowincome benchmark premium, the beneficiary pays the difference.17
Beneficiaries are not auto-enrolled into plans with premiums above
the benchmark. Drug plan premiums change each year; therefore,
a plan with a premium below the benchmark this year may have
a premium above the benchmark next year. If this happens, lowincome beneficiaries then must decide between staying in the same
plan—and paying the difference between the plan’s premium and
benchmark premium—or enrolling in another plan with a premium
below the benchmark. In 2009, about 2 million LIS beneficiaries are
enrolled in non-benchmark plans and are paying Part D premiums.18
Once a beneficiary chooses a plan on his or her own, CMS will not
9

July 31, 2009

National Health Policy Forum

Figure 3: Plans with Premiums At or Below
the Benchmark, 2006–2009
Region 1 has followed a typical pattern:
an increase in below-benchmark plans
from 2006 to 2007, but then a decline in
the number of plans for 2008 and 2009.

Region 1:
New Hampshire and Maine

reassign the beneficiary to another
plan, even if the beneficiary’s plan
has a premium above the benchmark in a future year.

A few regions, including
Texas, have observed only
a modest decline from
2006 to 2009.

Region 22: Texas

21

19

18

15

16

14

14

5

Region 29: Nevada

Nevada and Arizona have had a
relatively small number of plans
below the benchmark since the
start of the drug benefit in 2006.
For 2009, Nevada has 1 plan and
Arizona has two plans below the
benchmark.

9
7

5
1

Number of Below-Benchmark
Plans, Nationwide
640
495
409
308

Sources: Centers for Medicare & Medicaid Services, 2009 Landscape Source and
2008 Landscape Source, www.cms.hhs.gov/
PrescriptionDrugCovGenIn . 2007 and 2006
Landscape Source files no longer available
online; accessed April 2009. And "Medicare
Part D, Prescription Drug Plan (PDP) Availability in 2009," Kaiser Family Foundation,
November 2008, available at www.kff.org/
medicare/upload/7426_05.pdf.
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The policy rationale for Medicare
paying the full premiums only for
basic benefit plans with premiums
below the low-income benchmark
is to ensure that Medicare is not
paying for the most costly plans,
and to encourage plans to bid as
low as possible in order to attract
enrollment. If Medicare paid the
full premium of plans with higherthan-average premiums, program
costs would be higher, and plans
would have less incentive to bid
competitively.
The number of plans with premiums under the benchmark (and
therefore available to most lowincome beneficiaries at zero premium) and the variation in the
number available from region to
region are policy concerns. The
number of drug plans with premiums below the benchmark
generally increased between 2006
and 2007; since then, however, the
number of such plans generally
declined—with steep declines in
some regions. Indeed, all regions
except Wisconsin experienced a
decline in the number of plans
with premiums under the benchmark in 2009.19 Figure 3 highlights
notable patterns in the availability
of plans with premiums below the
benchmark. The 2006–2009 experience of Region 1 (New Hampshire
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and Maine) is typical: an increase in plans for 2007 followed by rather
steep declines in 2008 and 2009. (See also Appendix 1 for 2006–2009
regional low-income benchmark premiums and the number of plans
with premiums below the benchmark).
From a policy perspective, it is not clear what the “right” number of
plans with premiums below the benchmark should be. While some
might argue that many low-income beneficiaries would have difficulty comparing coverage among many plans and making a choice, others believe that choice should be as broad as possible. Some analysts
and advocates believe that providing plan choice allows individuals
the opportunity to select a plan whose formulary and other features
best meet their needs while encouraging plan innovation. Others
note that prior to implementation of Part D in 2006, most low-income
beneficiaries received their drug coverage through Medicaid—with
no choice of plans at all. In addition, states with the lowest numbers
of below-the-benchmark plans also have a high percentage of lowincome beneficiaries in Medicare managed care plans, so having
more choices of PDPs is less important. In any event, there is some
degree of discomfort among policymakers with the significant variation in the number of available zero-premium plans from one region
to another, as well as the discrepancy between the amount of choice
available to these beneficiaries compared to other beneficiaries.

D rug Pl a n Ava i l a bi l it y Over T ime
A second major policy issue related to the bidding and benchmarks
is that, because benchmark is calculated annually, each year the mix
of plans with premiums at or below the benchmark has changed. According to CMS, 2.2 million beneficiaries—about 23 percent of lowincome beneficiaries enrolled in PDPs and MA-PDs—were either
switched or were notified that they needed to switch to avoid paying
a premium (or an increased premium) for 2009. For 2008, 2.6 million
low-income beneficiaries were affected by these changes. Further,
recent analysis indicates that, of the 409 plans with premiums below the benchmark the first year of the drug benefit (2006), only 96
of them—23 percent—had premiums below the benchmark in 2007,
2008 and 2009.20 Some beneficiaries have been enrolled in two, three,
or more plans since the start of the program in 2006.
The number of beneficiaries switching plans is troubling from a policy
perspective for several reasons. First, it is confusing for beneficiaries.
11
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This population tends to have higher drug utilization, more chronic
health conditions (including mental health conditions), and cognitive impairments than the average American, all of which can make
frequent changes in drug plans more difficult. Understanding which
drugs are on plan formularies, which pharmacies are preferred, how
to manage an appeal or grievance, and how to contact the plan is particularly challenging for many in this population.
Second, beneficiaries may be subject to utilization management techniques (prior authorization or step therapy, for example) in one plan,
and be subject to different techniques in another plan the following
year. While utilization management techniques are widely used and
accepted tools, annual changes in the techniques and the drug substitutions may not be desirable, especially for this population. CMS
has requirements for short-term supplies of a drug during a transition period, but staying on a preferred drug long-term sometimes
requires effort by both the physician and the beneficiary. It is not yet
clear whether changing plans leads to widespread quality-of-care
issues, such as medication reactions because of therapeutic substitution or a confused beneficiary not refilling a prescription on time.
Third, the percentage of individuals switching plans is much higher
among low-income beneficiaries than in the non low-income population: only about 6 percent of non low-income beneficiaries change
Medicare drug plans in a given year. The experience of non low-income beneficiaries under Part D is consistent with that of of enrollees
in the Federal Employees Health Benefits Program—about 6 percent
of federal employees nationwide switch health insurance plans in any
given year.21 Non low-income individuals most often elect to stay in
their current plan, even if it costs more. It is worth noting that many
Medicare beneficiaries are faced with difficult choices and trade-offs in
spending each year, particularly when it comes to health care spending, and deciding whether to switch prescription drug plans because
of cost is only one such decision. However, some may feel that the
prospect of switching plans is a “price to pay” for the federal subsidy.
Fourth, there may be some modest hidden costs involved in switching plans. Plans incur costs educating new beneficiaries through
printed material and fielding beneficiary phone calls about new formularies and plan requirements. Pharmacy costs include counseling beneficiaries regarding formulary changes at the point of sale
and updating computer systems with new plan information. Physician offices may find that annual drug plan changes result in more
12
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of their time being spent on pharmacy issues as they handle plan
requests for medication changes. For some patients, drug switches
require an office visit, perhaps adding to Part B costs.

A C loser Loo k Beh i n d
A n n ua l Ch a n g es i n Pl a n O ptio n s
It is instructive to understand why plan options change for lowincome beneficiaries from year to year. The low-income benchmark
premium amount is key to this. It determines how many plans, and
which particular plans, are offered to low-income beneficiaries premium-free. The multi-year example in Appendix 2 illustrates how the
low-income benchmark is calculated, and how the number and mix
of plans with premiums below the benchmark change annually.22
Several issues contribute to the fluctuation of the premium and the
policy concerns described above that accompany it. These mostly
technical issues are worth considering as policymakers weigh options to reduce the number of low-income beneficiaries experiencing
a disruption of prescription drug coverage.
• Payment adequacy and risk adjustment. Payments to drug plans
are adjusted to reflect certain characteristics of all beneficiaries
including age, gender, and health status. Payments to plans on
behalf of low-income beneficiaries are further adjusted to reflect
the fact that low-income beneficiaries use more prescription
drugs than other beneficiaries. Some researchers and plans believe that the adjustments to plan payments may not be adequate
to account for these higher costs.23 If payments to a plan for lowincome beneficiaries do not accurately reflect the plan’s actual
costs in one year, then the plan may not bid as competitively
as possible in a future year to avoid the risk of covering lowincome beneficiaries. In the Part D bidding process, plans must
bid based on expected expenses and utilization, and plans must
not bid based solely on a strategy of including or excluding certain groups. However, there is some judgment in putting the
many pieces of bid information together to ensure that expenses
are covered. If plans feel that the payment is inadequate to account for the costs of low-income beneficiaries, then their bid
may reflect that belief. If the plan’s bid places its premium above
the benchmark, then beneficiaries would need to decide whether
to stay in the plan or enroll in a new plan below the benchmark.
If many below-benchmark plans conduct themselves in this
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manner, the result can be instability in plan choices for beneficiaries and perhaps higher premiums over time.
• Calculation of the low-income benchmark premium. Although
highly technical, the manner in which the low-income benchmark
premium is calculated is very important because even seemingly
modest changes may result in more plans or fewer plans having
premiums below the benchmark. For the first several years of the
drug benefit, the low-income benchmark premium was calculated
in a manner that some analysts believe kept the benchmark premium artificially high. CMS changed the calculation for 2009 and
future years. The calculation now involves multiplying the plan’s
premium by the percentage of LIS beneficiaries enrolled in the
plan.24 The policy rationale for this change was to better reflect the
premiums of plans that actually enroll LIS beneficiaries, and to reduce the effect of MA-PD premiums in the calculation (see below).
The overall result is intended to be a reduction in the number of
beneficiaries switching plans. It is not yet clear what the result
over time will be. However, some analysts are concerned that the
benchmark will actually be depressed over time.
• Inclusion of MA premiums in the calculation of the benchmark. The
drug portion of the MA premium is included in the benchmark
calculation, consistent with the statute. The inclusion of MA premiums depresses the benchmark because the MA-PD premium
amounts used in the calculation are lower on average than the
premiums of free-standing drug plans. The MA-PD premiums are
considered artificially low for purposes of the calculation because
MA-PDs are permitted to apply money saved providing benefits
under Parts A and B (known as rebates) to the premium amounts.
If MA plans were excluded from the benchmark, or if the premium amount did not include rebate dollars, the low-income benchmark premium likely would increase, and more plans would have
premiums below the benchmark.

Co n c lusio n
Reliance on competitive bidding to determine premiums and overall program costs is a hallmark of Medicare Part D. But the nature
of the bidding process has introduced instability in the number of
plans and the particular plans offered to low-income beneficiaries.
Consquently, low-income beneficiaries might not remain in a prescription drug plan over the long term. This fluctuation may lead
to beneficiary confusion around plan choices and enrollment. It is
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not clear whether or not frequent plan changes result in quality-ofcare issues, but that would be of great concern. And the instability
may prove costly both for pharmacies dealing with beneficiaries at
the point of sale and for physicians and their staffs who field phone
calls from pharmacies regarding medication changes at the request
of drug plans.
Congress is considering health reform legislation that would involve providing subsidies for the purchase of health insurance on an
income-related basis. Medicare’s Part D experience to date may be
instructive as proposals are refined. Providing the highest subsidy
level only to plans with average or below premiums has been a successful tool for keeping federal costs as low as possible. However,
there has been disruption in plan enrollment and choice for lowincome beneficiaries. Policymakers may want to consider the experience of low-income beneficiaries under Part D as they debate health
reform measures.

EN DN OT ES
1. Beneficiaries enrolled in one type of Medicare managed care plan, called a
private fee-for-service plan, may also enroll in a PDP because the private fee-forservice plan is not required to offer a prescription drug benefit.
2. For a discussion of how the bid is converted into a monthly beneficiary premium, please see Medicare Payment Advisory Commission (MedPAC), “Part D
Payment System,” paymentbasics, revised October 2008; available at www.medpac.gov/
documents/MedPAC_Payment_Basics_08_PartD.pdf.
3. Some beneficiaries switch to a lower-premium drug plan offered by the same
company or sponsor which may have the same formulary.
4. Employers offering a qualified drug benefit to Medicare-eligible retirees are
eligible to receive a subsidy from Medicare known as the retiree drug subsidy to
defray the cost of providing a drug benefit. In 2009, Medicare will pay roughly
$600 per beneficiary enrolled in such plans. See 2009 Annual Report of the Boards of
Trustees of the Federal Hospital Insurance and Federal Supplementary Medicare Insurance
Trust Funds, May 12, 2009, p.163; available at www.cms.hhs.gov/ReportsTrustFunds/
downloads/tr2009.pdf.
5. For more background information on the Medicare drug benefit please see
“The Medicare Drug Benefit (Part D),” National Health Policy Forum, The Basics,
January 15, 2009, available at www.nhpf.org/library/details.cfm/2708, and background
and presentation material from the fundamentals briefing, “Understanding Medicare and Medicaid: Fundamentals and Issues for the New Congress,” January 15,
2009, available at www.nhpf.org/briefbook09Tab5.cfm.
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6. 2009 Trustees Report, p. 120. Amount includes federal expenditures for the retiree drug subsidy.
7. 2009 Trustees Report, p. 163.
8. Nearly one-half million additional low-income beneficiaries have drug coverage from sources other than Medicare, such as the Veterans Administration (VA),
Indian Health Service (IHS), and state pharmaceutical assistance programs (SPAPs).
9. For all states, except Alaska, Hawaii, and DC, where separate guidelines apply.
Centers for Medicare & Medicaid Services (CMS), “Guidance to States on the Low-Income Subsidy,” February 2009; available at www.cms.hhs.gov/LowIncSubMedicarePresCov/
Downloads/StateLISGuidance021009.pdf.
10. See “The Role of Beneficiary-Centered Assignment for Medicare Part D,” a
study conducted by Georgetown University and NORC at the University of Chicago for MedPAC, June 2007, available at www.medpac.gov/documents/June07_Bene_
centered_assignment_contractor.pdf. Also see “Beneficiary-Centered Assignment and
Medicare Part D,” presentation to MedPAC by Jack Hoadley et al., September 4,
2008, available at www.medpac.gov/transcripts/Hoadley%20MedPAC%20presentation%20
09%2004%2008.pdf.
11. See, for example, CMS, “LIS Outreach Toolkit Numeric Maps,” April 2009;
available at www.cms.hhs.gov/Partnerships/99_LIS_Outreach_Toolkit_Numeric_Maps.
asp#TopOfPage.
12. CMS, “Formative Research on the Low Income Not Enrolled Population“; available at www.cms.hhs.gov/Partnerships/Downloads/Low_Income_Initial_Qualitative_Research.pdf.
13. See, for example, “Secretary Sebelius Announces Availability of $40 Million in Grants to Help Insure More Children,” U.S. Department of Health and
Human Services, press release, July 6, 2009; available at www.hhs.gov/news/
press/2009pres/07/20090706a.html.
14. MedPAC, Report to the Congress: Medicare Payment Policy, March 2009, p. 283;
available at www.medpac.gov/documents/Mar09_EntireReport.pdf.
15. There are 34 regions nationwide. Many regions encompass only one state, and
a few are multi-state.
16. The premium of a plan with very high LIS (low-income subsidy) enrollment
counts more in calculating the average than a plan with lower enrollment.
17. For 2007 and 2008, CMS permitted plans with premiums slightly above the
benchmark (a so-called de minimus amount above the benchmark)—$2 in 2007 and
$1 in 2008—to offer the plan at zero premium. The policy was discontinued beginning in 2009.
18. “Medicare Prescription Drug Plans in 2009 and Key Changes Since 2006: Key
Findings,” Elizabeth Hargrave et al. for Kaiser Family Foundation, June 2009;
available at www.kff.org/medicare/upload/7917.pdf.
19. MedPAC, Report to the Congress, March 2009, p. 291.
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20. Laura Summer et al., “Low-Income Subsidy Plan Availability,” Kaiser Family
Foundation, November 2008; available at www.kff.org/medicare/upload/7836.pdf.
21. MedPAC, Report to the Congress, March 2009, p. 277.
22. This example is for illustrative purposes only; the actual calculation is more
complex.
23. See, for example, work conducted for MedPAC by Dr. John Hsu, transcript from
MedPAC Public Meeting, October 2, 2008, pp. 7–21; available at www.medpac.gov/
transcripts/1002-1003MedPAC.pdf.
24. The regulation (CMS-4133-CN) making this change can be found at
www.cms.hhs.gov/PrescriptionDrugCovContra/Downloads/CMS4133C.pdf.
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Appen di x 1 ( ne x t pag e ) :
L ow - I n co m e P re miu m S u b s i d y A m o u n t s a n d N u m b e r of
Pla n s At o r Be low B e n ch m a r k , 20 0 6 – 20 0 9

There is a fair amount of variation in the low-income benchmark
premiums nationwide. For 2009, regional low-income benchmark
premiums ranged from a low of $16.22 in Arizona to a high of $38.15
in Wisconsin. There is also much variation in the number of drug
plans with premiums at or below the low-income benchmark premium in a region. For example, in 2009, Wisconsin beneficiaries may
choose among 16 plans below the benchmark, whereas Nevada beneficiaries only have 1 plan with premiums below the benchmark.
Most regions have between 8 and 12 zero-premium plans.
Sources: Centers for Medicare & Medicaid Services, 2009 Landscape Source and 2008 Landscape Source, www.cms.hhs.gov/PrescriptionDrugCovGenIn. 2007 and 2006 Landscape Source files
no longer available online; accessed April 2009. And "Medicare Part D, Prescription Drug Plan
(PDP) Availability in 2009," Kaiser Family Foundation, November 2008, available at
www.kff.org/medicare/upload/7426_05.pdf.
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Appen di x 1
Region / State

2006 ($)

Plans

2007 ($)

Plans

2008 ($)

Plans

2009 ($)

Plans

1

NH, ME

36.09

14

30.72

21

30.64

18

28.12

5

2

CT, MA, RI

30.27

11

27.35

20

29.17

14

31.74

12

3

NY

29.83

15

24.45

16

24.18

15

27.71

9

4

NJ

31.37

14

28.12

20

31.23

18

30.99

7

5

DE, DC, MD

33.46

15

29.65

21

30.78

18

30.85

11

6

PA, WV

32.59

15

28.45

26

26.59

18

29.23

9

7

VA

34.42

16

30.52

21

31.03

17

31.72

13

8

NC

36.30

13

32.13

21

33.43

17

33.45

11

9

SC

34.88

16

31.41

26

31.12

20

32.01

15

10

GA

33.15

14

31.07

21

30.04

18

29.16

11

11

FL

29.07

6

22.63

10

19.16

8

21.47

5

12

AL, TN

32.33

9

29.60

17

28.29

15

29.80

12

13

MI

33.22

14

30.79

26

30.49

17

32.08

11

14

OH

30.69

10

28.51

22

26.82

15

28.40

6

15

IN, KY

35.69

13

32.42

19

33.50

17

33.95

12

16

WI

31.27

14

29.67

21

31.03

16

38.15

16

17

IL

31.60

15

29.66

23

30.26

19

30.18

12

18

MO

31.37

10

27.88

15

26.71

13

31.89

6

19

AR

35.45

13

30.51

23

27.69

18

26.89

12

20

MS

36.39

12

31.70

21

31.35

15

31.53

13

21

LA

34.14

11

28.45

12

24.62

10

27.48

7

22

TX

31.68

16

26.93

19

25.01

15

25.36

14

23

OK

35.13

12

30.35

20

28.04

13

29.36

8

24

KS

33.44

11

30.56

20

30.62

17

33.66

10

25

IA, MN, MT

33.11

14

29.50

20

30.61

16

33.19

9

26

NM

25.95

8

22.72

14

19.28

11

20.55

7

27

CO

28.92

10

27.37

19

24.59

12

30.17

8

28

AZ

24.62

6

21.37

10

15.92

7

16.22

2

29

NV

23.46

7

20.56

9

16.64

5

20.20

1

30

OR, WA

30.60

15

28.71

20

30.19

15

31.76

7

31

ID, UT

33.62

14

31.77

20

33.53

14

37.46

9

32

CA

23.25

10

21.03

14

19.80

9

24.86

6

33

HI

27.44

8

26.35

18

24.32

10

25.01

5

34

AK

34.66

8

33.56

15

36.42

15

36.00

7

2006 Plans

409

2007 Plans

640

2008 Plans

495

2009 Plans

308

Total Plans*

* Includes de minimus plans for 2007 and 2008.
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Appen di x 2
H ow th e L ow - I n co m e B e n ch m a r k P re miu m
Af f e c t s O p tio n s fo r B e n e f i cia rie s : A M ul ti -Yea r E x a m p l e
This example illustrates the low-income benchmark calculation for the third, fourth and
fifth year of the drug benefit in a fictional region. There are 14 PDPs and 3 MA-PDs with
a range of premiums, and the low-income benchmark is $30.23. Low-income beneficiaries
qualifying for a zero-premium plan in this region have a choice of four PDPs and three
MA-PDs. A fifth PDP, whose premium is $31.00, will be permitted to offer their plan to
LIS beneficiaries for $30.23,
since the premium is a de
YEAR 3
minimus amount—less than
$1.00—above the benchIllustrative Low-Income Benchmark Premium Calculation
mark. In future years, the
Plan
Plan Share
de minimus rule will not apMonthly
Enrollment
of Average
Beneficiary
(% Beneficiaries
Weighted
ply, similar to what actualPlan
Premium ($)
Enrolled Last Year)
Premium
ly occurred under Part D.
17 PDP
64.00
1
.64

x

Year 3
Low-income

Benchmark = $30.23
* PDP 8 qualifies as a de minimus plan
in year 3 (see above).

16 PDP

62.00

2

1.24

15 PDP

53.00

2

1.06

14 PDP

47.00

8

3.76

13 PDP

46.00

6

2.76

12 PDP

43.00

5

2.15

11 PDP

42.00

7

2.94

10 PDP

38.00

6

2.28

9 PDP

36.00

3

1.08

8 PDP*

31.00

4

1.24

7 PDP

30.00

9

2.70

6 PDP

26.00

8

2.08

5 PDP

24.00

12

2.88

4 PDP

18.00

19

3.42

3 MA-PD

.00

2

.00

2 MA-PD

.00

2

.00

1 MA-PD

.00

6

.00

Low-Income Benchmark Premium
20

=

$30.23
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In year 4 of this multi-year example, depicted below, several pieces of the puzzle
change, quite similar to what actually occurred under Part D. First, plan premiums
increase. Second, the calculation of the benchmark premium changes, as it did under Part D for 2009. Rather than using enrollment of all beneficiaries, the new calculation only includes the percentage of low-income beneficiaries enrolled in each
of the plans. In addition, the de minimus policy is no longer in effect. PDP 4, which
had been the lowest premium plan with the largest market share, increases its premium to $38.00. Perhaps PDP 4’s cost experience warrants the increase, or perhaps
the plan does not bid as competitively as possible. The result is that PDP 4 now has
a premium above the low-income benchmark of $28.07. There are now two PDPs
and three MA-PDs with premiums below the benchmark. PDP 4—the most popular plan—and PDP 7 and PDP 8
are now no longer available to
YEAR 4
low-income beneficiaries at zero
Illustrative Low-Income Benchmark Premium Calculation
premium. Low-income beneficiaries qualifying for zero premium
Plan
Plan Share
Monthly
Enrollment
of Average
may stay in the plan and pay the
Beneficiary
(% LIS Beneficiaries
Weighted
additional premium, select and
Plan
Premium ($)
Enrolled Last Year)
Premium
enroll in another plan, or be au17 PDP
68.00
0
.00
tomatically enrolled in another
16 PDP
67.00
0
.00
plan by Medicare.

x

=

15 PDP

57.00

0

.00

14 PDP

52.00

0

.00

13 PDP

57.00

0

.00

12 PDP

50.00

0

.00

11 PDP

46.00

0

.00

10 PDP

46.00

0

.00

9 PDP

41.00

0

.00

4 PDP

38.00

29

11.02

8 PDP

35.00

0

.00

7 PDP

32.00

20

6.40

5 PDP

24.00

24

5.76

6 PDP

23.00

21

4.83

3 MA-PD

.00

2

.00

2 MA-PD

.00

3

.00

1 MA-PD

6.00

1

.06

Low-Income Benchmark Premium

Year 3
Low-income

Benchmark = $30.23
Year 4
Low-income

Benchmark = $28.07

$28.07
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In year 5, three MA-PDs now have premiums, perhaps because Medicare managed care payments decreased and plans decide to increase or add a premium for prescription drug coverage. Premiums have
increased across the board, as one would expect. In addition, PDP 4 has lost considerable market share,
and drops its premium. The overall result is a shift in the benchmark premium to $25.88, with one PDP
and three MA-PDs having premiums below the benchmark,
YEAR 5
somewhat similar to the realIllustrative Low-Income Benchmark Premium Calculation
world experience of Nevada in
2009. Notice that PDP 4 is back
Plan
Plan Share
Monthly
Enrollment
of Average
under the benchmark, so it is
Beneficiary
(% LIS Beneficiaries
Weighted
available to low-income benefiPlan
Premium ($)
Enrolled Last Year)
Premium
ciaries for zero premium. Some
17 PDP
70.00
0
.00
of the beneficiaries who were en16 PDP
69.00
0
.00
rolled in PDP 4 in year 3, disenrolled for year 4, are once again
15 PDP
59.00
0
.00
in PDP 4 for year 5.
14 PDP
54.00
0
.00

x

Year 3
Low-income

Benchmark = $30.23
Year 4
Low-income

Benchmark = $28.07
Year 5
Low-income

Benchmark = $25.88

=

13 PDP

61.00

0

.00

12 PDP

52.00

0

.00

11 PDP

52.00

0

.00

10 PDP

48.00

0

.00

9 PDP

43.00

0

.00

8 PDP

37.00

0

.00

7 PDP

34.00

3

1.02

6 PDP

26.00

45

11.70

5 PDP

26.00

46

11.96

4 PDP

25.00

3

.75

3 MA-PD

18.00

1

.18

2 MA-PD

15.00

1

.15

1 MA-PD

12.00

1

.12

Low-Income Benchmark Premium

$25.88

In this simplified multi-year example, the low-income benchmark premium has declined, and with it the number
of options available to most low-income beneficiaries for zero premium. While reality may differ from this example for many beneficiaries, for others it mirrors their experience under Part D. Plan premium amounts, plan enrollment, including MA-PDs in the calculation, plan willingness to attract low-income beneficiaries, and plan payment
(including risk adjustment) all play a role in determining which plans have premiums below the benchmark.
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